Natural Product: NPC483883

Natural Product IDNPC483883
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
SOTGPCCKMHIJCT-PDHFZSAVSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 44361783
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids
          • [CHEMONTID:0002051] Agarofurans

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SOTGPCCKMHIJCT-PDHFZSAVSA-N
Standard InCHI InChI=1S/C33H38O10/c1-18-25(36)26(39-19(2)34)28(42-30(38)22-15-11-8-12-16-22)32(6)24(41-29(37)21-13-9-7-10-14-21)17-23-27(40-20(3)35)33(18,32)43-31(23,4)5/h7-16,18,23-28,36H,17H2,1-6H3/t18-,23?,24+,25-,26+,27-,28+,32-,33?/m1/s1
SMILES C[C@@H]1[C@H]([C@@H]([C@@H]([C@@]2(C)[C@H](CC3[C@H](C12OC3(C)C)OC(=O)C)OC(=O)c1ccccc1)OC(=O)c1ccccc1)OC(=O)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   594.25 Volume:   598.079
?
Van der Waals volume.
Dense:   0.994 LogP:   3.044
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.095
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.531
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   10.0 Rigid Bonds:   30.0
TPSA:   134.66
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   1.0 Rings:   5.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.388 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.752 Fsp3:   0.515
MCE-18:   164.28
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.831 Fluc inhibitor:   0.014
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.009
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.061
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.12 Promiscuous compounds:   0.013

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.203 MDCK Permeability:   -4.794
Pgp-inhibitor:   0.999 Pgp-substrate:   0.414
PAMPA:   0.541
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.029 30% Bioavailability (F30%):   0.158
50% Bioavailability (F50%):   0.897

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.167 MRP1:   1.0
Plasma Protein Binding (PPB):   73.342% Volume Distribution (VD):   -0.187
Fu: 21.976%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   0.923 BCRP inhibitor:   0.115
BSEP inhibitor:   0.983

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.102
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.074
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.199 CYP3A4-substrate:   0.02
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.723
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.697 Half-life (T1/2):  0.594

ADMET: Toxicity

hERG Blockers:  0.049 hERG Blockers (10um):  0.59
Human Hepatotoxicity (H-HT):  0.118 Drug-induced Liver Injury (DILI):  0.894
AMES Toxicity:  0.312 Rat Oral Acute Toxicity:  0.142
Maximum Recommended Daily Dose:  0.162 Skin Sensitization:  0.985
Carcinogencity:  0.476 Eye Corrosion:  0.001
Eye Irritation:  0.29 Respiratory Toxicity:  0.034
Drug-induced Neurotoxicity:  0.496 Ototoxicity:  0.22
Hematotoxicity:  0.043 Drug-induced Nephrotoxicity:  0.292
Genotoxicity:  0.447 RPMI-8226 Immunitoxicity:  0.034
A549 Cytotoxicity:  0.413 Hek293 Cytotoxicity:  0.345
BCF:   0.747
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.66
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.424
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.878
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3859 Maytenus magellanica Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[11741484]
NPO10966 Maytenus chubutensis Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[11741484]
NPO10966 Maytenus chubutensis Species Celastraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO3859 Maytenus magellanica Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10966 Maytenus chubutensis Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. Inhibition = 11.7 % PMID[11741484]
NPT2 Others Unspecified n.a. Inhibition = 77.5 % PMID[11741484]
NPT2 Others Unspecified n.a. Inhibition = 3.5 % PMID[11741484]
NPT2 Others Unspecified n.a. Inhibition = 54.0 % PMID[11741484]
NPT2 Others Unspecified n.a. Inhibition = 0.0 % PMID[11741484]
NPT2 Others Unspecified n.a. Inhibition = 32.0 % PMID[11741484]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC483883 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC151585
0.7887 Intermediate Similarity NPC483865
0.7015 Intermediate Similarity NPC483862
0.6957 Remote Similarity NPC158663
0.6818 Remote Similarity NPC473081
0.6818 Remote Similarity NPC195647
0.6714 Remote Similarity NPC270590
0.6418 Remote Similarity NPC474608
0.6324 Remote Similarity NPC200592
0.6324 Remote Similarity NPC270498
0.6324 Remote Similarity NPC610542
0.6027 Remote Similarity NPC27377
0.5972 Remote Similarity NPC163087
0.5942 Remote Similarity NPC283375
0.5867 Remote Similarity NPC41481
0.5844 Remote Similarity NPC473112
0.5775 Remote Similarity NPC483863
0.5733 Remote Similarity NPC473673
0.5732 Remote Similarity NPC483864
0.5714 Remote Similarity NPC183122
0.5676 Remote Similarity NPC4341
0.5676 Remote Similarity NPC479047
0.5676 Remote Similarity NPC291638
0.5658 Remote Similarity NPC472574
0.5641 Remote Similarity NPC607428
0.561 Remote Similarity NPC184817
0.56 Remote Similarity NPC139067
0.56 Remote Similarity NPC43241
0.5541 Remote Similarity NPC17877
0.5467 Remote Similarity NPC48017
0.5455 Remote Similarity NPC479044
0.5455 Remote Similarity NPC92293
0.5443 Remote Similarity NPC473613
0.5443 Remote Similarity NPC473085
0.5405 Remote Similarity NPC475759
0.5405 Remote Similarity NPC483879
0.5385 Remote Similarity NPC266265
0.5366 Remote Similarity NPC483866
0.5342 Remote Similarity NPC475429
0.5342 Remote Similarity NPC476094
0.5316 Remote Similarity NPC210591
0.5316 Remote Similarity NPC184747
0.5278 Remote Similarity NPC481066
0.5263 Remote Similarity NPC191082
0.5244 Remote Similarity NPC88593
0.5244 Remote Similarity NPC14499
0.5233 Remote Similarity NPC473214
0.52 Remote Similarity NPC481067
0.52 Remote Similarity NPC241951
0.52 Remote Similarity NPC483847
0.5195 Remote Similarity NPC67777
0.5195 Remote Similarity NPC471101
0.5195 Remote Similarity NPC177340
0.5176 Remote Similarity NPC127026
0.5176 Remote Similarity NPC483890
0.5135 Remote Similarity NPC211137
0.5135 Remote Similarity NPC66761
0.5135 Remote Similarity NPC483843
0.5128 Remote Similarity NPC171207
0.5125 Remote Similarity NPC70716
0.5125 Remote Similarity NPC97667
0.5067 Remote Similarity NPC607964
0.5065 Remote Similarity NPC291599
0.5065 Remote Similarity NPC246480
0.5062 Remote Similarity NPC475652

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC483883 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data